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Abstract
Background: The few studies that have attempted to estimate the future cost of caring for people with dementia
in Australia are typically based on total prevalence and the cost per patient over the average duration of illness.
However, costs associated with dementia care also vary according to the length of the disease, severity of
symptoms and type of care provided. This study aimed to determine more accurately the future costs of dementia
management by taking these factors into consideration.
Methods: The current study estimated the prevalence of dementia in Australia (2010-2040). Data from a variety of
sources was recalculated to distribute this prevalence according to the location (home/institution), care
requirements (informal/formal), and dementia severity. The cost of care was attributed to redistributed prevalences
and used in prediction of future costs of dementia.
Results: Our computer modeling indicates that the ratio between the prevalence of people with mild/moderate/
severe dementia will change over the three decades from 2010 to 2040 from 50/30/20 to 44/32/24.
Taking into account the severity of symptoms, location of care and cost of care per hour, the current study
estimates that the informal cost of care in 2010 is AU$3.2 billion and formal care at AU$5.0 billion per annum. By
2040 informal care is estimated to cost AU$11.6 billion and formal care $AU16.7 billion per annum. Interventions to
slow disease progression will result in relative savings of 5% (AU$1.5 billion) per annum and interventions to delay
disease onset will result in relative savings of 14% (AU$4 billion) of the cost per annum.
With no intervention, the projected combined annual cost of formal and informal care for a person with dementia in
2040 will be around AU$38,000 (in 2010 dollars). An intervention to delay progression by 2 years will see this reduced
to AU$35,000.
Conclusions: These findings highlight the need to account for more than total prevalence when estimating the
costs of dementia care. While the absolute values of cost of care estimates are subject to the validity and reliability
of currently available data, dynamic systems modeling allows for future trends to be estimated.
Background
The type of care provided in Australia to persons with
dementia is primarily dependent on the severity of the
disease. In the milder stages of dementia, care is typically
at home and provided by a relative (informal carer).
However, as severity increases, informal care is often sup-
plemented by professional carers (formal care) largely
funded through the Commonwealth Aged Care Program
that target both the person with dementia and their carer
e.g. Community Aged Care Packages, Extended Aged
Care At Home Dementia Packages, and Dementia
Respite care. In the more severe stages of the disease,
persons with dementia are primarily institutionalised
in residential aged care facilities that also receive
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community and residential care in Australia requires an
assessment by an Aged Care Assessment team and
formal approval that the individual has sufficient disabil-
ity and needs to warrant Commonwealth funding [1].
This progression incurs a significant cost to both the
individual and the community, which will increase as the
prevalence of dementia increases [2].
According to a recent review [3], the few studies that
have attempted to model the future costs of caring for
people with dementia in Australia have assumed that
total cost will increase relative to total disease preva-
lence, and that interventions designed to delay disease
onset and/or progression will reduce prevalence, and
thereby cost.
Such assumptions limit the accuracy of cost estimates
unless they account for costs associated with patient
location, the severity of dementia, and the type of care
(informal/formal). Quentin et al. [4] recently published a
comprehensive review that highlighted the need to
account for the influence of these variables when estimat-
ing the cost of illness in studies of dementia. They found
that cost of care doubles as dementia severity progresses
from the mild to severe stage, and that patient location
determines the relative proportion of informal/formal
care a patient receives. Such results confirm the impor-
tance of a multidimensional approach to the calculation
of total costs of care for people with dementia.
The accuracy of cost estimates can be further enhanced
by accounting for projected dementia prevalence and the
impact of interventions on dementia severity-specific pre-
valence. Dementia prevalence in Australia will continue
to increase to 2040 and beyond [2]. The relative distribu-
tion of dementia severity-specific prevalence will also
change over time [2]. These factors influence cost esti-
mates. As the severity of dementia increases, so does the
need for informal and formal care, but once people with
dementia are placed in institutional care most of the
costs are relatively fixed, irrespective of cognitive decline
or activities of daily living (ADL) [5].
Numerous studies, such as those of Nepal and collea-
gues [3], Quentin and colleagues [4], and the Alzhei-
mer’s Association [6] have varied in their estimates of
predicted costs associated with future projections of
dementia prevalence, but all demonstrate predicted
increases in both the prevalence and related cost of
dementia. These projections do not, however, attempt to
estimate the future cost of dementia care by taking into
account the influence of location, type of care, and
dementia severity over time. This study aimed to build
upon such models by more accurately determining the
costs associated with dementia by taking these factors
into account.
We developed a computational model to forecast the
prevalence of mild, moderate and severe dementia in
Australia 2010-2040 [2]. Data from a variety of sources
[2] [7-9] were recalculated to redistribute total preva-
lence according to the location, care type required, and
dementia severity of the person with dementia. Cost
data from an alternative set of sources [7] [10,11] were
applied to our redistributed prevalence estimates,
thereby providing a unique estimate of dementia care
costs in Australia 2010-2040.
Virtual experiments examined the impact on total pre-
valence of delaying disease progression by 2 years and
delaying disease onset by 2 years. Cost estimations were
carried out for each of these scenarios.
In essence, predictive modeling relies on sourcing the
most valid and reliable data available, and then recalculat-
ing those data over time. As such a process relies on var-
ious estimates and assumptions, computer modeling in
research does not aim to provide, nor can it report, defini-
tive results. Rather, predictive modeling attempts to
demonstrate possible outcomes derived from the para-
meters included, be they theoretical or actual.
This study aggregated data from a variety of sources to
produce current (2010) estimates of dementia prevalence
by location, care type, dementia severity, and relative care
costs. Prevalence was then extrapolated across the next
three decades using the dementia prevalence model [2],
and costs recalculated accordingly.
Taking 2010 values as a baseline measure of prevalence
and cost, it is the relative changes predicted by the model
over time that are of most interest - absolute values are
(due to the limitations of available data) a “best guess”,a n d
easily recalculated if/when more accurate data becomes
available. However, the direction and magnitude of preva-
lence shift over time is considerably more accurate.
As such, the main focus of the current study is the
dynamism of prevalence shifts over time, and the conse-
quent impact on total cost of care.
Aims
1. To integrate research estimates of the hours of infor-
mal and formal care provided to dementia patients
according to the severity of disease and patient location/
care setting.
2. To project the severity-specific prevalence of
dementia in Australia 2010 - 2040 using the dementia
prevalence model [2].
3. To examine impact of an intervention to slow dis-
ease progression by 2 years.
4. To examine impact of an intervention to delay dis-
ease onset by 2 years.
5. To estimate the change in costs of informal and for-
mal care for dementia patients in Australia 2010 - 2040.
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The dementia prevalence model was used to calculate
severity-specific prevalences of dementia (Australia 2010
- 2040) as well as the impact over time of interventions
introduced in 2010 (Table 1) [2]. The Dementia Preva-
lence Model is a computer model designed to estimate
the prevalence of dementia in Australia, and involves
ascribing characteristics representative of dementia
patients (such as age, mortality, dementia severity), and
then ‘aging’ these over 30 years. The model identified
various trajectories of dementia prevalence depending on
whether interventions were established and at what stage
these were introduced. As is common in the literature [3]
[8] [12], we chose to model feasible interventions that
could either a) delay the disease progression from mild
dementia to moderate dementia by 2 years (i.e. everyone
with mild dementia would take an additional two years
to progress to a more moderate form of the disease), or
b) delay the onset of dementia by 2 years (i.e. everyone
would take an additional 2 years to get dementia, but
then progress to a more moderate form of the disease at
the same rate as if there had been no intervention).
While such interventions are not currently available,
advances in the diagnosis of dementia and dementia
treatment will likely play a role in delaying the onset or
slowing the progression sometime in the near future. For
example, the existence of a healthy lifestyle might be a
preventative measure in developing dementia [13], and
advances in the early detection of dementia might delay
onset by allowing earlier pharmacological treatment.
The data provided by the dementia prevalence model
[2], the work of Brookmeyer and colleagues [8], and
reports concerning dementia prevalence and cost by
Access Economics [7] [9] were used to calculate the rela-
tive prevalence of dementia severity (mild/moderate/
severe) by location and care type. Total dementia preva-
lence for Australia in 2010 was distributed between
dementia severities by location and care type (see Table 2:
2010 values).
These models [2] [8] provided the ratio of mild:mod-
erate:severe dementia (5:3:2 for 2010) and Access Eco-
nomics [7] provided percentage splits for location and
type of care. From these data sets values for dementia
severity by location/care type were triangulated.
Costs specific to the dependent relationship between
these variables (location, care type, dementia severity)
were then attributed to the dementia population 2010-
2040 using 2010 Australian dollar (AU$) values; (approxi-
mately parity with US$ in Sept 2011). Values for informal/
formal hours of care per person with dementia, and the
cost of informal/formal care per hour per person with
dementia were calculated from the data of Access Eco-
nomic [7] [9], the World Health Organisation [10] and the
Australian Institute of Health and Welfare [11].
For formal hours of care, values ranging from 39 hr/pa
for a person with mild dementia living at home with a
family, to 1512 hr/pa for a person with severe dementia
living in a residential aged care facility were adopted [[7]
Table E1]. The assumptions regarding informal hours of
care are not clearly reported in published literature. Total
hours of care per week for a person living with dementia
at home are estimated to be about 8.5 hr for mild, 25.0
hours for moderate and 41.5 hours for severe dementia
[[9] Table 15 p.47]. Total hours per annum can be calcu-
lated for informal care as 445 (mild), 1304 (moderate), and
2165 (severe). Similarly, if care at home is shared with
help from formal carers the informal hours of care are
reduced to 404 (mild), 619 (moderate) and 1141 (severe)
hours per annum. Informal care hours when the patient
was living in residential aged care (distinguished from
social visits) were at the level of only 1 hr (mild), 2.5 hr
(moderate) and 5 hr (severe) per week [9]. Hours of care
for patients grouped by location, type of care received, and
by severity of dementia are presented in Table 3. The lit-
erature is unclear as to how reliable these estimates are.
Estimates of the the hourly cost of care are AU$27 (2009
values) for low level (informal) care [[7] p.49] with an
additional increase by 20% for high level (formal) [11] care
to AU$33.
Costs were calculated according to the formula (where
s - severity, and l - location):
Cost(Total) =

(s, l) CostInformal care +

(s, l) Cost(Formal care)
Costs were calculated by multiplying each of the loca-
tion/care-type/dementia severity specific prevalence
values by the number of informal/formal care hours per
person with dementia (pwd) per year to arrive at the total
Table 1 Dementia prevalence in Australia 2010 - 2040 with and without interventions
No intervention Delay progression Delay onset
Mild Mod Severe Total Mild Mod Severe Total Mild Mod Severe Total
2010 117,000 71,000 44,000 232,000 117,000 71,000 44,000 232,000 117,000 71,000 44,000 232,000
2020 168,000 111,000 75,000 354,000 204,000 96,000 64,000 364,000 139,000 57,000 94,000 290,000
2030 242,000 166,000 120,000 528,000 295,000 144,000 104,000 543,000 202,000 84,000 140,000 426,000
2040 327,000 235,000 182,000 744,000 402,000 205,000 159,000 766,000 279,000 120,000 210,000 609,000
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multiplied by the care cost per hour (2010 equivalent).
For example;
￿ In 2010, 5800 patients with severe dementia live at
home and receive both informal and formal care.
￿ These patients each receive 1141/1023 hours of
informal/formal care respectively per year.
￿ This translates to 7.0 million hours of informal
care and 5.9 million hours of formal care provided
to these patients in 2010.
￿ At a care cost of $27/hour, this equates to AU$188
million for informal care and AU$160 million for
formal care for persons with severe dementia who
live at home (2010).
The impact of interventions to delay disease progres-
sion/onset on dementia prevalence was then calculated.
For further information on the Dementia Prevalence
Model, including a sensitivity analysis, see [2] [14].
Results
An examination of the severity specific prevalence of
dementia in Australia (2010 - 2040) reveals that severity
ratios change over time (Figure 1). Even in the absence
of an intervention (no delay in onset/progression),
severity ratios will change due to changing demo-
graphics [2].
Without the influence of an intervention there will be
6% fewer cases of mild dementia by 2040. The introduc-
tion of interventions to delay disease progression/onset
by 2 years likewise alters the severity-specific prevalence
of dementia. If all persons with mild dementia take an
extra two years to progress to moderate dementia, there
will be 8% more cases of mild dementia in 2040 relative
to no delay. If an intervention introduced in 2010 delays
disease onset by 2 years, there will only be 2% more
cases of mild dementia in 2040 relative to no delay.
There will, however, be 11% more cases of severe
dementia due to the accumulating effect of already diag-
nosed cases.
Table 2 Dementia severity by location and type of care
Total dementia population (2010)
N = 232000 Severity Percent of total Prevalence (2010)
Location Type of care setting
Mild (0.6) 21% 48720
Home (35%) Community; informal care with no formal care Moderate (0.3) 10.50% 24360
Severe (0.1) 3.50% 8120
Mild (0.6) 15% 34800
Home (25%) Community; mixture of informal and formal care Moderate (0.3) 7.50% 17400
Severe (0.1) 2.50% 5800
Institutions (40%) Mild (0.35) 14% 32480
RAC 1-4 RAC 5-8 Institutions; mixture of informal and formal care Moderate (0.3) 12% 27840
(33%) (7%) Severe (0.35) 14% 32480
Total 100% 232000
Table 3 Hours of informal/formal care per person with dementia per year by dementia severity, location, and type of
care (estimates from available literature)
Total dementia population (2010)
N = 232000 Severity Hours per person with dementia per year
Location Type of care setting Informal Formal
Mild (0.6) 445 .
Home (35%) Community; informal care with no formal care Moderate (0.3) 1304 .
Severe (0.1) 2165 .
Mild (0.6) 404 39
Home (25%) Community; mixture of informal and formal care Moderate (0.3) 619 685
Severe (0.1) 1141 1023
Institutions (40%) Mild (0.35) 75 1355
RAC 1-4 RAC 5-8 Institutions; mixture of informal and formal care Moderate (0.3) 150 1512
(33%) (7%) Severe (0.35) 250 1512
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over time. Informal/formal costs of care in 2010 for
patients grouped by location and type of care received,
and by severity of dementia are presented in Table 4
(2010 values). Projected costs of dementia in Australia
2010 - 2040 are presented in Table 5.
In the absence of intervention, the total cost of
dementia care in Australia in 2010 is AU$8.2 billion
dollars, 61% of which is accounted for by formal care
costs. In 2040 the total cost will rise to AU$28.3
billion dollars, 59% of which will be accounted for by
formal care costs (Table 5). An intervention to slow
the progression of dementia by 2 years will result in a
5% saving (AU$1.5 billion) per annum by 2040; an
intervention to delay the onset of dementia by 2 years
will result in a 14% saving (AU$4 billion) per annum
by 2040.
The relationship between cost and prevalence is
dynamic, and mediated by the interaction between
dementia severity and formal/informal costs. Figure 2
Figure 1 Relative change in severity-specific dementia prevalence in Australia 2010-2040 with and without interventions.
Table 4 Informal/formal costs by location and type of care, and dementia severity for 2010
Total dementia population (2010)
N = 232000 Severity Informal (AU$) Formal (AU$)
Location Type of care setting
Mild 585,370,800 .
Home (35%) Community; informal care with no formal care Moderate 857,666,000 .
Severe 474,654,600 .
Mild 385,236,000 37,584,000
Home (25%) Community; mixture of informal and formal care Moderate 328,860,000 321,813,000
Severe 187,920,000 160,201,800
Institutions (40%) Mild 65,772,000 1,452,343,200
RAC 1-4 RAC 5-8 Institutions; mixture of informal and formal care Moderate 112,752,000 1,378,080,000
(33%) (7%) Severe 219,240,000 1,714,944,000
Total 3,217,472,200 5,064,966,000
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valence over time. Such dynamic relationships are con-
sistent beyond absolute cost estimates, which fluctuate
according to the accuracy/reliability of available data.
Relative to a 2010 baseline (100%), 2040 prevalence
has increased to 322% in the no delay scenario. Under
the influence of an intervention to delay progression by
2 years, there is a 10% relative increase in 2040 preva-
lence, taking it to 332%. On the contrary, an interven-
tion to delay onset by 2 years will result in a 58%
relative reduction of prevalence, to 264% of 2010 values.
This is the comparison highlighted on the graph. The
same logic can equally be applied to informal, formal, or
total cost.
The delay onset scenario results in the lowest overall
values for both total cost and prevalence, but the highest
cost per person with dementia (Table 6). Formal costs
per person with dementia are relatively stable across all
scenarios - it is the informal care cost that is changing
most.
Table 5 Cost of dementia care (informal/formal) in Australia 2010 - 2040 with and without interventions ($A billion
dollars 2010 equivalent)
No intervention Delay progression (2 yr) Delay onset (2 yr)
Informal Formal Total Informal Formal Total Informal Formal Total
2010 3.2 5.0 8.2 . . . . . .
2020 5.1 7.8 12.9 4.5 7.8 12.3 4.8 6.5 11.3
2030 8.0 11.7 19.7 7.1 11.7 18.7 7.2 9.6 16.8
2040 11.6 16.7 28.3 10.2 16.6 26.8 10.5 13.8 24.3
Figure 2 Relative change in dementia prevalence and formal/informal costs in Australia 2010-2040 with and without interventions.
Dotted lines illustrate the difference in prevalence between the scenarios at 2040.
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care costs of dementia based on total prevalence alone
ignores many influential dynamics:
￿ Prevalence and cost of care both increase over
time
￿ In the absence of any intervention (no delay) by
2040;
○ Total prevalence increases to 322% relative to
2010 values (100%)
○ Total formal costs increase to 203% relative to
2010 values (100%)
○ Total informal costs increase to 142% relative
to 2010 values (100%)
￿ An intervention to delay disease progression by
2 years will, over time;
○ Increase total prevalence relative to the no
delay condition
○ Reduce overall cost relative to the no delay
condition
￿ An intervention to delay disease onset by 2 years
will, over time;
○ Reduce total prevalence relative to the no delay
condition
○ Reduce overall cost relative to the no delay
condition
The current analysis does not take into account the
cost of interventions as it is difficult to estimate these
costs when such treatments are not yet viable. Possible
interventions could take any form (e.g. regular exercise
or pharmacological treatments) which would vary consid-
erably in their respective cost. Given this ambiguity,
attempting to estimate the cost of these potential inter-
ventions would be inappropriate. In order to demonstrate
the potential cost of a hypothetical intervention, the cur-
rent per annum cost of donepezil [15] was used as repre-
senting the possible cost of a treatment that would either
delay progression or onset of dementia (Table 7).
Discussion
T h ec u r r e n ts t u d ya d d r e s s e sag a pi nt h el i t e r a t u r et h a t
evaluates the cost of dementia [3]. The formal and infor-
mal costs of care in different stages of dementia progres-
sion were estimated for Australia 2010-2040. The fiscal
impact of therapeutic interventions to delay disease onset
and progression was similarly evaluated. Previous studies
have not simultaneously accounted for severity specific
costs while recognising the distinction between formal
and informal costs of care. The current cost of dementia
in Australia is calculated to be AU$8.2 billion per
annum, with formal care accounting for 61% of the total.
By 2040, these costs will have increased to AU$28.3 bil-
lion per annum, 59% of which would be spent on formal
care. As noted previously, absolute values such as these
need to be interpreted with caution due to the lack and
inconsistency of data available. However, estimates of the
prevalence shift over time are considerably more accu-
rate, and are more likely to remain constant with changes
in these values. Our results indicate that slowing the pro-
gression of dementia by 2 years will result in a 10% rela-
tive increase in the total prevalence of dementia by 2040
relative to the no delay scenario. Such a result, while not
intuitive, is due to higher rates of severe dementia in the
no delay scenario, and the respective increase in mortal-
ity. Despite this increased prevalence, the relative cost of
care will be reduced by AU$1.5 billion per annum, as the
milder stages of dementia are associated with lower costs.
Delaying the onset of dementia by 2 years will result in a
relative reduction of both prevalence and total cost.
These results highlight the need for cost estimation to
account for more than total prevalence.
A more interesting dynamic is observed when the
annual cost per person with dementia is examined.
Under the influence of an intervention that successfully
delays the onset of dementia by 2 years both prevalence
and total cost are reduced relative to no intervention.
However, the total cost of care per person with dementia
per annum in 2040 is $2000 more expensive than the no
Table 6 Cost of dementia care per person with dementia per annum (informal/formal/total) in Australia 2040 with and
without interventions ($A)
No Intervention Delay Progression (2 yr) Delay Onset (2 yr)
Informal 15,600 13,400 17,200
Formal 22,400 21,600 22,600
Total 38,000 35,000 40,000
Table 7 Cost of hypothetical intervention in Australia
2010 - 2040 ($A dollars 2011 equivalent)
Delay Progression Delay Onset
2010 237,042,000 237,042,000
2020 413,304,000 281,614,000
2030 597,670,000 409,252,000
2040 814,452,000 565,254,000
Values obtained by multiplying the current per annum cost of donepezil (~AU
$2026 per person) by the projected prevalence of mild dementia in 2010-
2040. While an intervention to delay onset would be administered before the
onset of mild dementia, costs were calculated on this basis in the absence of
appropriate data
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delay progression condition.
In light of these findings, it is pertinent to question tra-
ditional notions of success when evaluating potential inter-
ventions - be they economic or clinical in nature. The
intervention most beneficial at a population level (delay
onset; lowest prevalence/total cost) places the greatest fis-
cal burden on individuals and their families. Whereas the
intervention that leaves society with the greatest number
of people with dementia also results in the lowest cost per
person with dementia per annum. These differences in
cost per person are driven by informal costs, and would
thereby be more likely a burden on the individual than the
government. In designing future objectives, policy decision
makers need to question who pays, and who benefits from
any potential interventions.
The driving force behind these dynamics is severity-
specific prevalence. The relative number of patients with
mild/moderate/severe symptoms changes over time, and
differentially according to the influence of interventions.
Disease progression is strongly associated with a transi-
tion from mostly informal to mostly formal care. Differ-
ent types of care and different care settings are associated
with different costs.
Many factors determine the current costs, but there is
agreement that the main component is the cost of for-
mal care, which rises as dementia progresses. People
with moderate dementia often transition from mostly
informal to mostly formal care. This includes the shift
from home based care in the community to residential
or institution-based care. Benefits of care interventions,
medications and non-medication therapies, policies of
early detection and policies of providing more formal
care in the community are justified by how much they
avoid institutionalisation. Controversies arise because
there are large differences in informal care hours and
costs. In addition, the effects of dementia on the quality
of life of both people with dementia and their carers are
difficult to quantify with appropriate economic social
and environmental measures (triple line accounting)
that include distributions of costs and benefits among
individuals.
For a clearer approach to costing we recommend the
following:
￿ Consistent definitions of progression of dementia
using and reporting multiple dimensions, the level of
cognitive impairment, estimated time from onset of
symptoms, level of assistance with activities of daily liv-
ing (ADL) or disability weights, with an agreed comor-
bidity scale for both physical and mental disorders.
￿ Clearly distinguish between cost of illness and cost of
caring for people with dementia. In most cases it is better
to count the whole cost of individual care rather than
artificially split this cost in complex patients into
fractional disease components among many interacting
diagnoses.
￿ Focus on costing the transition from informal to for-
mal care within the moderate stage of dementia. This
includes using the person with disability (with their net-
work of informal and formal carers) as the unit of analy-
sis of costs and including the value of positive
experiences and wellbeing as benefits to participants in
this care network [16].
While it is likely that similar trajectories of prevalence
exist in other western countries, where rates of dementia
and the types of care are comparable, estimates of
dementia prevalence can vary considerably. For example,
the current model differs to a report by the Alzheimer’s
Association [6] in estimates of baseline and future rates
of mild, moderate and severe dementia with or without
intervention. Specifically the report demonstrates higher
rates of severe dementia and lower rates of mild demen-
tia than the current study (e.g. 28:31:41 [6] compared to
50:30:20 (mild:moderate:severe) at 2010 baseline). Similar
levels of variability can be seen in the projected costs of
formal and informal care of dementia in Australia. A
recent assessment of future costs [11] estimated the cost
of dementia in 2030-2031 at AU$4.5 billion, considerably
less than the AU$19.7 billion projected by this study. A
possible explanation for such a finding is that the current
study accounted for not only formal costs of care, as the
other estimate was based, but also costs associated with
informal care. It is likely that this discrepancy is also due
to more recent estimates of dementia prevalence being
utilised in the current study. The capability of any model
to adequately account for prevalence rates and costs
associated with dementia is largely reliant on the data
available to this end, and is modulated by social norms,
expectations and the provision of care in these varying
populations. As a result, comparing studies is not always
appropriate as each study aims to achieve a ‘best guess’ in
their estimates and assumptions. Applying the dementia
prevalence model with a variety of parameters in various
populations would be a useful indicator of the cost of for-
mal and informal care in Australia and internationally.
The current study is limited by the costing data cur-
rently available to model, and perhaps this goes some
way to explaining the lack of research in the area [3]. An
accurate estimation of formal and informal costs by
severity is difficult at present. Available published data
are fragmented and different government agencies have
different reporting requirements, with generally only the
global costs of formal and informal care available for ana-
lysis. Such inconsistency disallowed many costs to be
included in this study.
A more collaborative approach to this problem will
enhance cost estimates and future policy decisions.
Assumptions regarding duration of illness [17] and average
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edge in these areas. For example, if delay in onset of
dementia increases life span, this would merely shift costs
some years hence rather than reduce them. In future these
assumptions may change significantly and so will the pro-
jected outcomes. As patient and carer networks change
frequently, especially during the moderate phase of
dementia, methods that account for this dynamic dimen-
sion will be able to allocate costs and benefits using activ-
ity based costing methods. Costs can be allocated to both
disease states and transitions, independent of states. For
example the costs associated with newly diagnosed
dementia cases might occur at any stage of dementia,
rather than these costs always allocated to the mild stage
of dementia. New advances with biomarker technology for
early detection of dementia may in fact increase demand
on services in very early stages of disease [19].
Many additional factors influence the costs of care,
and these may change in future. For example, labour
costs may change relative to a supply-demand cycle for
workers in residential aged care facilities. The replace-
ment costs for informal care may also be calculated dif-
ferently if the retirement age increases. Carers 65 years
and older and still in the work force will convert from
paid employment to a role of informal carer at much
higher replacement cost.
A further limitation of this study is that the costs asso-
ciated with the interventions could not be included in the
analysis as the cost of such interventions are yet to be
known. It is obvious that costs will be incurred with any
measure introduced to delay or slow the progression of
dementia. While the cost of a hypothetical intervention
was estimated based on the current cost of donepezil,
costs of potential treatments remain unknown.
Estimating care costs for dementia, now and in the
future, requires a more detailed analysis than total preva-
lence alone can provide. The potential of interventions
that prolong disease progression, or delay disease onset to
produce savings in terms of prevalence, or cost of care, or
both is exciting. However, savings at an aggregated level
are not necessarily passed on to the individual. The com-
plexities of predicting trends in such a dynamic system
necessitate that clinicians and policy makers take time to
consider who pays, and who benefits from interventions.
Conclusions
The few studies that have attempted to model the future
costs of caring for people with dementia in Australia
have assumed that total cost will increase relative to total
disease prevalence, and that interventions designed to
delay disease onset and/or progression will reduce preva-
lence, and thereby cost. Such assumptions limit the accu-
racy of cost estimates unless they account for costs
associated with patient location, the severity of dementia,
and the type of care (informal/formal).
Results from the dementia prevalence model predict
that both prevalence and cost of care increase over time,
however, an intervention to delay disease progression by
2 years will increase prevalence and reduce overall care
costs over time. On the other hand, an intervention to
delay disease onset by 2 years will reduce both preva-
lence and overall care costs over time.
These findings highlight the need to account for more
than total prevalence when estimating the costs of
dementia care. Variables such as location, care type, and
dementia severity can significantly enhance the accuracy
of estimates, especially when predicting the future costs
of dementia care. While the absolute values of cost of
care estimates are subject to the validity and reliability
of currently available data, dynamic systems modeling
allows for future trends to be estimated.
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